4/28/2014 | BKHYPF | S&P lowers Vantage Oncology
|
10/31/2013 | HY | New Issue: Vantage Oncology prices $50 million tap of 91/2% notes due 2017 at par
|
10/31/2013 | HY | Market Commentary: Upsized Kinder Morgan megadeal, Capsugel lead $2 billion session; funds gain $753 million
|
10/31/2013 | HY | Vantage Oncology intends to price $50 million tap of 91/2% secured notes due 2017 on Thursday
|
10/31/2013 | BKHYPF | S&P: Vantage Oncology unchanged after add-on
|
5/22/2013 | HY | New Issue: Vantage Oncology sells $250 million four-year notes at par to yield 91/2%
|
5/22/2013 | HY | Market Commentary: CommScope, Provident, Legacy, Vantage price in $1.8 billion day; US Air makes return flight
|
5/22/2013 | HY | Vantage Oncology talks $250 million four-year notes to yield 91/2% area
|
5/21/2013 | BKHY | Moody's rates Vantage notes B2
|
5/20/2013 | HY | Market Commentary: B&G Foods, Sabra bring deals; Concho, Memorial Production do add-ons; calendar keeps building
|
5/20/2013 | HY | Vantage Oncology set to price $250 million four-year secured notes this week
|
5/20/2013 | BK | Vantage Oncology to repay loan borrowings with notes proceeds
|
5/20/2013 | BKHY | S&P assigns B to Vantage Oncology notes
|
3/24/2011 | BK | S&P rates Vantage B, Physician Oncology loan B
|
2/28/2011 | BK | Market Commentary: Texas Competitive trades up with alleged default; Visant, Vantage Oncology, Playboy break
|
2/22/2011 | BK | Market Commentary: Michael Foods, Kalispel break; Vantage, Affordable, Serena, Carestream, Cedar tweak deals
|
2/22/2011 | BK | Vantage Oncology cuts pricing on term B, adds $25 million delayed draw
|
2/10/2011 | BK | S&P: Physician Oncology, loan B
|
2/10/2011 | BK | Market Commentary: Gymboree tweaks deal, levels rise; Reynolds, Affinion, Oriental Trading, Sedgwick break
|
2/10/2011 | BK | Vantage Oncology launches $221 million term B at Libor plus 525 bps
|
2/1/2011 | BK | Market Commentary: Gymboree dips; National Surgical, IWCO break; GEO sets spread; Summit, AccentCare reveal talk
|
2/1/2011 | BK | Vantage Oncology to launch $246 million credit facility on Feb. 10
|
7/11/2008 | BK | Vantage Oncology obtains $100 million term loan through Ares Capital
|